StoneStable, Inc.

StoneStable uses silica to coat viruses and biologicals to improve gene transduction

  • Stage Product In Development
  • Industry Biotechnology
  • Location Portland, OR, USA
  • Currency USD
  • Founded December 2014
  • Employees 2
  • Incorporation Type C-corp
  • Website stonestable.com

Company Summary

StoneStable, Inc. is the silica-stabilization company. Our technology reversibly coats viral vectors, vaccines and other biologicals in silica. This process confers enhanced immune response, greater transduction efficiency and confers stability in widely varying environmental conditions. Currently we are focussing on applying our technology to cell and gene therapies.

Team

  • CSO and Founder

    Professor of Biology, Portland State University
    Affiliate Professor of Chemical Pharmacology and Biochemistry, OHSU
    Co-Founder, Center for Life in Extreme Environments
    Chair NASA Virus Focus Group
    Co-Founder, StoneStable, Inc.
    Published over 80 papers and book chapters
    Co-inventor of StoneStable technology
    Over 100 media appearances
    Previously worked at Sandoz, now Novartis, and Genentech
    Obtained over 6 million dollars in research grants

  • CEO Auxetics
    Partner, BridgeWorks Capital, LLC
    MS. MBA
    Ex - Merrill and Nike

Advisors

  • Chief, Laboratory of Immunologic Monitoring, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center
    Sandra Shotwell
    President and COO DesignMedix, Managing Partner, Alta Biomedical Group LLC, CEO Elex Biotech
    Unconfirmed
    Dan Snyder
    Unconfirmed
  • John Bial
    Unconfirmed
    Mark Slifka
    Unconfirmed
  • Giovanni Magni
    Unconfirmed
    Kyle Gee
    Unconfirmed

Previous Investors

  • Elevate Capital
    Unconfirmed
    ONAMI
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free